Trial
NCT02987504
Study of Samalizumab in Patients With Advanced Cancer
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Alexion Pharmaceuticals, Inc.
Collaborators
Quintiles, Inc.
Condition
Advanced Solid Tumors
Intervention
Samalizumab
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-07-18